During the past decade, Charles River Medical Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles River Medical Associates" #1 sponsor was "Pfizer" with 2 trials, followed by "Brigham and Women's Hospital" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored and "HealthCore-NERI" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles River Medical Associates" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Karolinska University" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Charles River Medical Associates" are "Cardiovascular Disease" (2 trials), "Myocardial Infarction" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Charles River Medical Associates" in a lesser frequency.

Most popular intervention types in "Charles River Medical Associates" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Spironolactone" (2 trials), "bococizumab (PF-04950615)" (2 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "High Dose Trivalent Influenza Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charles River Medical Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Charles River Medical Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Charles River Medical Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Charles River Medical Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".